ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements
Maxposure Limited responded to an NSE surveillance query stating no undisclosed material information explains the price movement. The company attributed the movement to general market conditions.
Maxposure Limited sent Reg 36(1)(b) web-link letters to unregistered-email shareholders for its FY25-26 Annual Report and 20th AGM notice. No transaction or business event is disclosed.
Maxposure Limited scheduled its 20th Annual General Meeting for September 30, 2026. The company also announced book closure dates for the AGM.
Maxposure Limited announced the re-appointment of Ms. Sweta Johari as Whole-time Director and Mr. Prakash Johari as Managing Director for three-year terms effective November 2026.
Maxposure Ltd's board approved re-appointments for its MD and Whole-time Director and proposed migration from NSE SME to the Main Board.
Maxposure Limited announced a board meeting for September 3, 2026. This intimation provides advance notice of the upcoming meeting agenda.
Maxposure acquired an additional 3.8% stake in Neutral Digital Limited for Rs. 0.77 Crore. Total shareholding now reaches 96.2%, strengthening its position in aviation-focused immersive platforms.
Maxposure's subsidiaries Aerohub and Aeroplay partnered with Myanmar Airways International to launch wireless inflight entertainment. This deployment covers MAI's entire fleet using a BYOD platform.
Maxposure Limited filed its SDD Compliance Certificate for the financial year ended March 31, 2026. The certificate confirms adherence to SEBI's insider trading database regulations.
Maxposure Limited re-appointed M/s. Arun K Agarwal & Associates as Internal Auditors for a twelve-month term. The decision was finalized during a board meeting on May 26, 2026.
Maxposure Limited re-appointed M/s Arun K Agarwal & Associates as Internal Auditors for the 2026-27 financial year. This appointment ensures continuity in internal compliance and auditing.
Maxposure Limited disclosed related party transactions totaling ₹1.47 Crore for the half-year ended March 31, 2026. The filing fulfills mandatory SEBI listing compliance requirements.
Maxposure Limited reported consolidated total income of ₹88.76 Crore for FY2026. The results include a variation in IPO proceeds utilization for strategic aviation acquisitions.
Maxposure Limited reported full utilization of ₹20.26 Crore IPO proceeds. Shareholders previously approved a variation in objects for strategic acquisition and investment in the aviation industry.
Maxposure Ltd reported revenue from operations of ₹42.5 Cr (+32.0% YoY) and net profit of ₹4.4 Cr (+25.7% YoY) for H2 FY26.
Maxposure Limited approved audited standalone and consolidated results for the year ended March 31, 2026. The group reported a consolidated annual net profit of ₹9.48 Crore.
Maxposure Limited confirmed Regulation 24A secretarial compliance reporting is not applicable as an SME-listed entity. This routine regulatory filing clarifies the company's reporting obligations.
Maxposure Limited scheduled a board meeting on May 26, 2026, to approve audited annual financial results. The trading window remains closed until May 28, 2026.
Maxposure Limited has declared the non-applicability of Corporate Governance provisions under SEBI LODR Regulations for FY 2026–27. As a company listed on the NSE SME platform, it fulfills the criteria for exemption under Regulation 15(2). Consequently, the submission of a Corporate Governance Report is not required.
Maxposure Limited has confirmed it does not meet the criteria to be identified as a 'Large Corporate' or 'Large Entity' as of March 31, 2026. This disclosure is in compliance with SEBI Circulars regarding fund raising through debt securities.